The generic name for besponsa is Inotuzumab ozogamicin injection and is helpful in treating adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Some side effects of besponsa include:
fatigue,
bleeding,
fever,
nausea,
headache
constipation,
vomiting,
swelling and sores inside the mouth,
Chills.
Besponsa 1 mg powder for concentrate for solution for infusion.1 ml solution consists of 0.2 mg Inotuzumab ozogamicin.